| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glioblastoma | 11 | 2024 | 327 | 3.250 |
Why?
|
| Brain Neoplasms | 14 | 2024 | 1207 | 2.890 |
Why?
|
| Neoplastic Stem Cells | 10 | 2024 | 291 | 2.890 |
Why?
|
| Chromatin | 6 | 2023 | 551 | 1.920 |
Why?
|
| Caenorhabditis elegans | 6 | 2011 | 223 | 1.280 |
Why?
|
| Medulloblastoma | 4 | 2025 | 325 | 1.200 |
Why?
|
| Caenorhabditis elegans Proteins | 6 | 2011 | 88 | 1.130 |
Why?
|
| Glioma | 2 | 2023 | 487 | 1.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 12 | 2025 | 1895 | 1.060 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2022 | 209 | 0.710 |
Why?
|
| Butyrophilins | 1 | 2020 | 1 | 0.690 |
Why?
|
| Cell Self Renewal | 2 | 2021 | 43 | 0.680 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2020 | 77 | 0.670 |
Why?
|
| Cerebellar Neoplasms | 4 | 2025 | 275 | 0.660 |
Why?
|
| Longevity | 3 | 2011 | 137 | 0.650 |
Why?
|
| Genes, Homeobox | 2 | 2023 | 70 | 0.610 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2016 | 118 | 0.600 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 669 | 0.590 |
Why?
|
| Histones | 3 | 2023 | 526 | 0.570 |
Why?
|
| Carcinogenesis | 1 | 2020 | 331 | 0.570 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 1079 | 0.530 |
Why?
|
| Epigenesis, Genetic | 6 | 2024 | 673 | 0.510 |
Why?
|
| Gene Expression Profiling | 7 | 2022 | 1702 | 0.490 |
Why?
|
| Cancer Care Facilities | 1 | 2025 | 31 | 0.480 |
Why?
|
| Genes, Helminth | 3 | 2011 | 22 | 0.480 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 780 | 0.470 |
Why?
|
| DNA Methylation | 6 | 2024 | 1003 | 0.470 |
Why?
|
| Anion Transport Proteins | 2 | 2011 | 30 | 0.450 |
Why?
|
| Mutation | 8 | 2025 | 5825 | 0.450 |
Why?
|
| Cell Differentiation | 5 | 2024 | 1891 | 0.450 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 1485 | 0.430 |
Why?
|
| Medical Oncology | 1 | 2025 | 212 | 0.420 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2019 | 1140 | 0.420 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2012 | 66 | 0.390 |
Why?
|
| Cell Proliferation | 7 | 2025 | 2287 | 0.390 |
Why?
|
| Precision Medicine | 1 | 2025 | 319 | 0.380 |
Why?
|
| Cell Line, Tumor | 8 | 2025 | 3339 | 0.370 |
Why?
|
| Genes, Mitochondrial | 1 | 2011 | 17 | 0.370 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2024 | 294 | 0.350 |
Why?
|
| SOXB1 Transcription Factors | 2 | 2024 | 57 | 0.340 |
Why?
|
| Animals | 19 | 2025 | 34085 | 0.330 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 176 | 0.330 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 3153 | 0.320 |
Why?
|
| Mitochondria | 2 | 2011 | 682 | 0.320 |
Why?
|
| Pheromones | 1 | 2009 | 16 | 0.320 |
Why?
|
| Adenosine Triphosphate | 1 | 2010 | 282 | 0.310 |
Why?
|
| Ependymoma | 2 | 2024 | 125 | 0.310 |
Why?
|
| Humans | 27 | 2025 | 124601 | 0.300 |
Why?
|
| Energy Metabolism | 2 | 2011 | 775 | 0.300 |
Why?
|
| DNA-Binding Proteins | 2 | 2015 | 2045 | 0.290 |
Why?
|
| Whole Genome Sequencing | 2 | 2020 | 280 | 0.290 |
Why?
|
| Mice, SCID | 4 | 2025 | 568 | 0.290 |
Why?
|
| Neoplasms | 3 | 2025 | 2772 | 0.280 |
Why?
|
| Genome, Human | 3 | 2024 | 1273 | 0.280 |
Why?
|
| Xenograft Model Antitumor Assays | 4 | 2019 | 882 | 0.270 |
Why?
|
| Tumor Cells, Cultured | 3 | 2019 | 1062 | 0.270 |
Why?
|
| Mice | 11 | 2025 | 17639 | 0.270 |
Why?
|
| Tumor Microenvironment | 3 | 2025 | 555 | 0.270 |
Why?
|
| Fatty Acids | 1 | 2009 | 346 | 0.260 |
Why?
|
| Signal Transduction | 4 | 2025 | 4504 | 0.250 |
Why?
|
| Insulin | 1 | 2011 | 1202 | 0.250 |
Why?
|
| Genomics | 3 | 2024 | 1502 | 0.250 |
Why?
|
| Meninges | 1 | 2025 | 18 | 0.240 |
Why?
|
| Mice, Inbred NOD | 3 | 2015 | 285 | 0.240 |
Why?
|
| Epigenomics | 3 | 2024 | 163 | 0.240 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2020 | 1032 | 0.240 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2025 | 16 | 0.240 |
Why?
|
| Molecular Targeted Therapy | 2 | 2019 | 354 | 0.240 |
Why?
|
| Promoter Regions, Genetic | 3 | 2018 | 1328 | 0.230 |
Why?
|
| Apoptosis | 1 | 2011 | 1789 | 0.230 |
Why?
|
| Transcription Factors | 4 | 2025 | 2584 | 0.210 |
Why?
|
| Meningeal Neoplasms | 1 | 2025 | 185 | 0.210 |
Why?
|
| Genetic Heterogeneity | 2 | 2024 | 126 | 0.210 |
Why?
|
| Prognosis | 4 | 2023 | 4625 | 0.210 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2023 | 76 | 0.200 |
Why?
|
| RNA, Long Noncoding | 1 | 2024 | 211 | 0.190 |
Why?
|
| Astrocytoma | 1 | 2022 | 98 | 0.190 |
Why?
|
| Child | 6 | 2024 | 24374 | 0.180 |
Why?
|
| Genomic Structural Variation | 1 | 2022 | 86 | 0.180 |
Why?
|
| Lactobacillus johnsonii | 1 | 2020 | 1 | 0.180 |
Why?
|
| Larva | 3 | 2011 | 247 | 0.180 |
Why?
|
| Inosine | 1 | 2020 | 11 | 0.180 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2021 | 143 | 0.180 |
Why?
|
| Intestinal Neoplasms | 1 | 2020 | 39 | 0.170 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2022 | 763 | 0.170 |
Why?
|
| Bifidobacterium | 1 | 2020 | 62 | 0.170 |
Why?
|
| Mitochondrial Proteins | 2 | 2011 | 229 | 0.170 |
Why?
|
| Forkhead Transcription Factors | 3 | 2022 | 356 | 0.170 |
Why?
|
| GPI-Linked Proteins | 1 | 2020 | 100 | 0.170 |
Why?
|
| Translocation, Genetic | 1 | 2022 | 357 | 0.160 |
Why?
|
| B7 Antigens | 1 | 2019 | 9 | 0.160 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 310 | 0.160 |
Why?
|
| Disease | 1 | 2020 | 129 | 0.160 |
Why?
|
| Primary Cell Culture | 1 | 2019 | 101 | 0.160 |
Why?
|
| Models, Biological | 1 | 2024 | 1459 | 0.150 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 660 | 0.150 |
Why?
|
| Cell Lineage | 2 | 2017 | 338 | 0.150 |
Why?
|
| Transcriptome | 1 | 2024 | 952 | 0.150 |
Why?
|
| Germ-Line Mutation | 1 | 2020 | 332 | 0.150 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 869 | 0.150 |
Why?
|
| Drosophila | 1 | 2022 | 782 | 0.150 |
Why?
|
| Telomerase | 1 | 2018 | 160 | 0.140 |
Why?
|
| Genome | 1 | 2020 | 472 | 0.140 |
Why?
|
| Cell Tracking | 1 | 2017 | 15 | 0.140 |
Why?
|
| Databases, Genetic | 1 | 2020 | 473 | 0.140 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 257 | 0.140 |
Why?
|
| CpG Islands | 2 | 2018 | 323 | 0.140 |
Why?
|
| Drosophila Proteins | 1 | 2022 | 716 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2010 | 997 | 0.130 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2020 | 555 | 0.120 |
Why?
|
| Oxidative Stress | 2 | 2011 | 802 | 0.120 |
Why?
|
| Immunotherapy | 1 | 2020 | 670 | 0.120 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1322 | 0.120 |
Why?
|
| DNA Copy Number Variations | 1 | 2020 | 949 | 0.120 |
Why?
|
| Drug Design | 1 | 2015 | 147 | 0.120 |
Why?
|
| Female | 9 | 2025 | 66492 | 0.110 |
Why?
|
| Canada | 1 | 2025 | 288 | 0.110 |
Why?
|
| RNA Interference | 1 | 2015 | 498 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2013 | 59 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 1697 | 0.110 |
Why?
|
| Transfection | 1 | 2015 | 1062 | 0.110 |
Why?
|
| Melanoma | 1 | 2020 | 834 | 0.110 |
Why?
|
| Hedgehog Proteins | 1 | 2014 | 185 | 0.110 |
Why?
|
| Skin Neoplasms | 1 | 2020 | 808 | 0.100 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2013 | 87 | 0.100 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2020 | 700 | 0.100 |
Why?
|
| Information Dissemination | 1 | 2025 | 186 | 0.100 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1684 | 0.100 |
Why?
|
| Phenotype | 4 | 2021 | 4256 | 0.100 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2013 | 136 | 0.100 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 237 | 0.100 |
Why?
|
| Male | 6 | 2024 | 61199 | 0.100 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2012 | 157 | 0.090 |
Why?
|
| bcl-X Protein | 1 | 2011 | 31 | 0.090 |
Why?
|
| Aging | 2 | 2010 | 1182 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 2634 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 124 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 1645 | 0.090 |
Why?
|
| Subcellular Fractions | 1 | 2011 | 97 | 0.090 |
Why?
|
| Pediatrics | 1 | 2020 | 1163 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 504 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 355 | 0.090 |
Why?
|
| Blotting, Western | 1 | 2012 | 1102 | 0.090 |
Why?
|
| Adult | 3 | 2022 | 29440 | 0.080 |
Why?
|
| Life Expectancy | 1 | 2010 | 53 | 0.080 |
Why?
|
| Germ Cells | 1 | 2011 | 194 | 0.080 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 275 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 390 | 0.080 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 1660 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 1016 | 0.080 |
Why?
|
| Temperature | 1 | 2010 | 303 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1690 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 485 | 0.080 |
Why?
|
| Time Factors | 2 | 2015 | 6292 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2011 | 767 | 0.070 |
Why?
|
| Models, Animal | 1 | 2010 | 460 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 356 | 0.070 |
Why?
|
| Protein Binding | 1 | 2011 | 1738 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2013 | 837 | 0.070 |
Why?
|
| Transforming Growth Factor beta | 1 | 2009 | 457 | 0.060 |
Why?
|
| Membrane Proteins | 1 | 2013 | 1533 | 0.060 |
Why?
|
| Molecular Sequence Data | 2 | 2014 | 3878 | 0.060 |
Why?
|
| Cell Line | 1 | 2011 | 2750 | 0.060 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2025 | 23 | 0.060 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2025 | 44 | 0.060 |
Why?
|
| Embryonic Structures | 1 | 2025 | 6 | 0.060 |
Why?
|
| Metencephalon | 1 | 2025 | 7 | 0.060 |
Why?
|
| Animals, Genetically Modified | 1 | 2006 | 314 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 658 | 0.060 |
Why?
|
| Infratentorial Neoplasms | 1 | 2024 | 30 | 0.060 |
Why?
|
| Loss of Function Mutation | 1 | 2025 | 149 | 0.050 |
Why?
|
| Biglycan | 1 | 2023 | 7 | 0.050 |
Why?
|
| Spatial Analysis | 1 | 2023 | 21 | 0.050 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 5 | 1 | 2022 | 2 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2015 | 14009 | 0.050 |
Why?
|
| Young Adult | 1 | 2015 | 9014 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 2705 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2022 | 167 | 0.050 |
Why?
|
| Hypoxia | 1 | 2022 | 247 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2021 | 59 | 0.040 |
Why?
|
| Receptor, Adenosine A2A | 1 | 2020 | 10 | 0.040 |
Why?
|
| CTLA-4 Antigen | 1 | 2020 | 53 | 0.040 |
Why?
|
| Homeodomain Proteins | 1 | 2022 | 543 | 0.040 |
Why?
|
| Neoplasms, Experimental | 1 | 2020 | 211 | 0.040 |
Why?
|
| B7-H1 Antigen | 1 | 2020 | 114 | 0.040 |
Why?
|
| Oxygen | 1 | 2022 | 553 | 0.040 |
Why?
|
| Antibodies | 1 | 2020 | 373 | 0.040 |
Why?
|
| Gene Expression | 1 | 2022 | 1562 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2018 | 301 | 0.040 |
Why?
|
| Stochastic Processes | 1 | 2017 | 34 | 0.040 |
Why?
|
| Adolescent | 1 | 2015 | 19278 | 0.040 |
Why?
|
| Clone Cells | 1 | 2017 | 166 | 0.030 |
Why?
|
| Heterografts | 1 | 2017 | 171 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 374 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 617 | 0.030 |
Why?
|
| Infant | 2 | 2024 | 12468 | 0.030 |
Why?
|
| Plicamycin | 1 | 2014 | 3 | 0.030 |
Why?
|
| Patched Receptors | 1 | 2014 | 26 | 0.030 |
Why?
|
| Smoothened Receptor | 1 | 2014 | 28 | 0.030 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2014 | 26 | 0.030 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2013 | 3 | 0.030 |
Why?
|
| Antigens, Nuclear | 1 | 2014 | 60 | 0.030 |
Why?
|
| Rhombencephalon | 1 | 2014 | 46 | 0.030 |
Why?
|
| Neuropeptides | 1 | 2014 | 113 | 0.030 |
Why?
|
| Gene Fusion | 1 | 2013 | 55 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2014 | 235 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 244 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 163 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2013 | 406 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2014 | 189 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 469 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2020 | 1709 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 292 | 0.020 |
Why?
|
| Brain | 1 | 2023 | 2983 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 4409 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1689 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2014 | 717 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 2393 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 1112 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2014 | 1265 | 0.020 |
Why?
|
| RNA, Helminth | 1 | 2006 | 8 | 0.020 |
Why?
|
| Binding Sites | 1 | 2006 | 1295 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2006 | 759 | 0.010 |
Why?
|